NDC 73069-164

Viatrexx-Facial

Adrenal, Collagen, Cutis, Diosorea, Epithelial Growth Factor, Erythrocytes, Fumaric Acid, Funiculus, Gingko, Hyaluronidase, Il 1 - Beta, Kalum Aspariticum, Multi B Vitamin Complex (b 1,2,3,5,6,9,12), Muscle, Natrum Oxalaceticum, Natrum Pyruvicum, Placenta, Quinhydrone, Succinic Acid, Silicea And Trifolium

Viatrexx-Facial is a Intramuscular; Intravenous; Parenteral; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Viatrexx Bio Incorporated. The primary component is Sus Scrofa Adrenal Gland; Bos Taurus Adrenal Gland; Pork Collagen; Cuminaldehyde; Dioscorea Villosa Tuber; Sus Scrofa Red Blood Cell; Bos Taurus Red Blood Cell; Fumaric Acid; Sus Scrofa Umbilical Cord; Bos Taurus Umbilical Cord; Ginkgo; Hyaluronidase; Potassium Aspartate; Thiamine; Riboflavin; Pantothenic Acid; Pyridoxine; Cyanocobalamin; Folic Acid; Pork; Beef; Sodium Diethyl Oxalacetate; Sodium Pyruvate; Sus Scrofa Placenta; Bos Taurus Placenta; Quinhydrone; Succinic Acid; Silicon Dioxide; Red Clover; Interleukin-1 .beta. Human; Bos Taurus Skin; Sus Scrofa Skin; Niacin.

Product ID	73069-164_2a9ceaa9-f69c-413b-b196-4da2dd72df14
NDC	73069-164
Product Type	Human Prescription Drug
Proprietary Name	Viatrexx-Facial
Generic Name	Adrenal, Collagen, Cutis, Diosorea, Epithelial Growth Factor, Erythrocytes, Fumaric Acid, Funiculus, Gingko, Hyaluronidase, Il 1 - Beta, Kalum Aspariticum, Multi B Vitamin Complex (b 1,2,3,5,6,9,12), Muscle, Natrum Oxalaceticum, Natrum Pyruvicum, Placenta, Quinhydrone, Succinic Acid, Silicea And Trifolium
Dosage Form	Injection
Route of Administration	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS
Marketing Start Date	2019-03-29
Marketing Category	UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler Name	VIATREXX BIO INCORPORATED
Substance Name	SUS SCROFA ADRENAL GLAND; BOS TAURUS ADRENAL GLAND; PORK COLLAGEN; CUMINALDEHYDE; DIOSCOREA VILLOSA TUBER; SUS SCROFA RED BLOOD CELL; BOS TAURUS RED BLOOD CELL; FUMARIC ACID; SUS SCROFA UMBILICAL CORD; BOS TAURUS UMBILICAL CORD; GINKGO; HYALURONIDASE; POTASSIUM ASPARTATE; THIAMINE; RIBOFLAVIN; PANTOTHENIC ACID; PYRIDOXINE; CYANOCOBALAMIN; FOLIC ACID; PORK; BEEF; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUS SCROFA PLACENTA; BOS TAURUS PLACENTA; QUINHYDRONE; SUCCINIC ACID; SILICON DIOXIDE; RED CLOVER; INTERLEUKIN-1 .BETA. HUMAN; BOS TAURUS SKIN; SUS SCROFA SKIN; NIACIN
Active Ingredient Strength	31 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL
Pharm Classes	Endoglycosidase [EPC],Glycoside Hydrolases [CS],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT],Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE],Non-Standardized Animal Skin Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Cells, Epidermal [EXT],Allergens [CS],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Cells, Epidermal [EXT],Allergens [CS],Non-Standardized Animal Skin Allergenic Extract [EPC],Nicotinic Acid [EPC],Nicotinic Acids [CS]
NDC Exclude Flag	N
Listing Certified Through	2020-12-31

Packaging

NDC 73069-164-39

100 VIAL, MULTI-DOSE in 1 BOX (73069-164-39) > 5 mL in 1 VIAL, MULTI-DOSE

Marketing Start Date	2019-05-06
NDC Exclude Flag	N
Sample Package?	N

NDC SPL Data Element Entries

NDC 73069-164-16 [73069016416]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-61 [73069016461]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-12 [73069016412]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-65 [73069016465]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-86 [73069016486]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-19 [73069016419]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-66 [73069016466]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-41 [73069016441]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-05

NDC 73069-164-14 [73069016414]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-37 [73069016437]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-38 [73069016438]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-29 [73069016429]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-64 [73069016464]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-39 [73069016439]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-45 [73069016445]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-68 [73069016468]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-69 [73069016469]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-35 [73069016435]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-71 [73069016471]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-06-19

NDC 73069-164-54 [73069016454]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-67 [73069016467]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-52 [73069016452]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-75 [73069016475]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-21 [73069016421]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-57 [73069016457]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-24 [73069016424]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-84 [73069016484]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-79 [73069016479]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-73 [73069016473]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-88 [73069016488]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-85 [73069016485]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-74 [73069016474]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-18 [73069016418]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-44 [73069016444]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-05

NDC 73069-164-27 [73069016427]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-78 [73069016478]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-49 [73069016449]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-63 [73069016463]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-47 [73069016447]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-81 [73069016481]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-87 [73069016487]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-22 [73069016422]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-36 [73069016436]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-62 [73069016462]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-83 [73069016483]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-46 [73069016446]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-05

NDC 73069-164-43 [73069016443]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-76 [73069016476]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-15 [73069016415]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-53 [73069016453]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-17 [73069016417]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-51 [73069016451]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-89 [73069016489]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-32 [73069016432]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-25 [73069016425]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-58 [73069016458]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-77 [73069016477]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-33 [73069016433]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-42 [73069016442]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-05

NDC 73069-164-31 [73069016431]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-23 [73069016423]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-48 [73069016448]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-72 [73069016472]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-11 [73069016411]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-59 [73069016459]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-28 [73069016428]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-34 [73069016434]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-82 [73069016482]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-55 [73069016455]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-26 [73069016426]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-13 [73069016413]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-164-56 [73069016456]

Viatrexx-Facial INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

SPL SET ID:	fc0409ad-ff8b-4bb0-b688-ccd6fad1a4f3
Manufacturer	VIATREXX BIO INCORPORATED
UNII	I8442U2G7J 6CA025Y4FG 5W4FLB0U2C ETJ7Z6XBU4 X62226112J 88XHZ13131 8KOG53Z5EM 83AL37E3A7 7J12CD6O9L O0893NC35F 118OYG6W3H OC4598NZEQ 2679MF687A 19F5HK2737 M2776SWB29 IWY3IWX2G8 3EM4VW6TQN P6YC3EG204 5X23IGF970 C8CV8867O8 TLM2976OFR 935E97BOY8 KV2JZ1BI6Z E2LC2A33SN AB6MNQ6J6L P4A66LQ3QJ L9153EKV2Y X66NSO3N35 O138UB266J 4PIB2155QP POD38AIF08 398IYQ16YV 19FUJ2C58T
PHarm Class EPC	Vitamin B6 Analog [EPC]
UPC Code	0073069164426 0073069164419
NUI Code	N0000005657 N0000175452 N0000192800